
Join to View Full Profile
710 W 168th StNew York, NY 10032
Phone+1 212-305-1710
Fax+1 212-305-1658
Dr. Elkind is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1993 - 1996
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1992 - 1993
Harvard Medical SchoolClass of 1992
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 1996 - 2028
NJ State Medical License 2007 - 2027
CT State Medical License 2007 - 2025
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2015-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2015-2017
Clinical Trials
- Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START) Start of enrollment: 2005 Sep 01
- Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- Design and procedures for the greenness, cognitive performance and vascular outcomes in the northern Manhattan study (NOMAS-greenness).Scott Charles Brown, Julius Roderik Dewald, Andrew G Rundle, Sarah Tom, Tatjana Rundek
American Journal of Epidemiology. 2026-07-07 - The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.Hyunmi Choi, Jose Gutierrez, Tian Wang, Minghua Liu, Cheng-Shiun Leu
Epilepsia. 2026-07-02 - White matter hyperintensities, cognitive decline and dementia risk in a community- dwelling cohort of northern Manhattan.Brenno Barreto, Huaizhi Ge, Mohammad Nafeli, Vanessa Guzman, Bonnie Levin
Research Square. 2026-06-04
Other
- Cryptogenic strokeElkind MS, Prabhakaran S
http://www.uptodate.com/contents/cryptogenic-stroke
UpToDate, Wolters Kluwer Health - 2012-10-25 - Decompressive hemicraniectomy for malignant middle cerebral artery territory infarctionElkind MS, Gupta R
http://www.uptodate.com/contents/decompressive-hemicraniectomy-for-malignant-middle-cerebral-artery-
UpToDate, Wolters Kluwer Health - 2012-02-10
Press Mentions
Heavy Drinking Can Cause Earlier, More Severe StrokeNovember 10th, 2025
Want to Prevent Dementia? This Body Part Might Have an Outsized RoleJuly 21st, 2025
17 Ways to Keep Your Brain Healthy as You AgeApril 14th, 2025
Grant Support
- FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
- FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
- Neurology Research Education And Mentorship ProgramNational Institute Of Neurological Disorders And Stroke2010–2012
- Stroke Incidence And Risk Factors In A Tri-Ethnic RegionNational Institute Of Neurological Disorders And Stroke2008–2012
- Neuroprotection With Statin Therapy For Acute Recovery Trial (NEUSTART)National Institute Of Neurological Disorders And Stroke2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









